Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.

Regidor DL, Detels R, Breen EC, Widney DP, Jacobson LP, Palella F, Rinaldo CR, Bream JH, Martínez-Maza O.

AIDS. 2011 Jan 28;25(3):303-14. doi: 10.1097/QAD.0b013e32834273ad.

2.

Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.

Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC.

Circulation. 2009 Feb 10;119(5):671-9. doi: 10.1161/CIRCULATIONAHA.108.807362. Epub 2009 Jan 26.

3.

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, Van Wyck D, Kopple JD, Kalantar-Zadeh K.

J Am Soc Nephrol. 2008 Nov;19(11):2193-203. doi: 10.1681/ASN.2008010014. Epub 2008 Jul 30.

4.

Epoetin dosing and dialysis facility ownership.

Regidor DL, Kalantar-Zadeh K, Kovesdy CP.

JAMA. 2007 Aug 22;298(8):862; author reply 862-3. No abstract available.

PMID:
17712068
5.

Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic?

Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K.

Clin J Am Soc Nephrol. 2006 Jan;1(1):70-8. Epub 2005 Nov 23.

6.

Serum and dialysate potassium concentrations and survival in hemodialysis patients.

Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K.

Clin J Am Soc Nephrol. 2007 Sep;2(5):999-1007. Epub 2007 Aug 16.

7.

Target haemoglobin concentrations in chronic kidney disease.

Regidor DL, Kalantar-Zadeh K.

Lancet. 2007 May 5;369(9572):1515-1516. doi: 10.1016/S0140-6736(07)60701-6. No abstract available.

PMID:
17482977
8.

A1C and survival in maintenance hemodialysis patients.

Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K.

Diabetes Care. 2007 May;30(5):1049-55. Epub 2007 Mar 2.

PMID:
17337501
9.

Impact of kidney bone disease and its management on survival of patients on dialysis.

Lee GH, Benner D, Regidor DL, Kalantar-Zadeh K.

J Ren Nutr. 2007 Jan;17(1):38-44. Review.

PMID:
17198930
10.

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.

Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD.

Kidney Int. 2006 Aug;70(4):771-80. Epub 2006 Jul 5.

11.

Longitudinal associations between dietary protein intake and survival in hemodialysis patients.

Shinaberger CS, Kilpatrick RD, Regidor DL, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K.

Am J Kidney Dis. 2006 Jul;48(1):37-49.

PMID:
16797385
12.

Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.

Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K.

J Am Soc Nephrol. 2006 Apr;17(4):1181-91.

13.

Time-dependent associations between iron and mortality in hemodialysis patients.

Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG.

J Am Soc Nephrol. 2005 Oct;16(10):3070-80. Epub 2005 Jul 20.

Supplemental Content

Loading ...
Support Center